Immunovant Inc. held its Annual Meeting of Stockholders on August 27, 2025. Jacob Bauer, Douglas Hughes, and Robert Susman were elected to the Board of Directors. The selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending March 31, 2026, was ratified. Additionally, the compensation of Immunovant's named executive officers was approved on a non-binding advisory basis.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunovant Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001764013-25-000132), on August 28, 2025, and is solely responsible for the information contained therein.